1Passlick B. Micrometastases in non-small cell lung cancer [J]. Lung Cancer, 2001,34(Suppl 3 ) : S25-29.
2Gusterson B. Are micrometastases clinically relevant? [J]. Br J Hosp Med, 1992,47(4) :247-248.
3Nicholson A G, Graham A N, Pezzella F, et al. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? [J]. Lung Cancer, 1997,18(3):231- 240.
4Chen Z L, Perez S, Holmes E C, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma [J]. J Natr Cancer Inst, 1993,85 (6) : 483-488.
5Osaki T, Oyama T, Gu C D, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage Ⅰ small-cell lung cancer [J]. J Clin Oncol, 2002,20(13): 2930-2936.
6Maruyama R, Sugio K, Mitsudomi J, et al. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage Ⅰ non-small-cell lung cancer [J]. J Thorac Cardiovasc Surg, 1997,114(4) :535-543.
7Vollmer R T, Govindan R, Graziano S L, et al. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer:an early measure of response [J]. Clin Cancer Res, 2003,9 (5) : 1728-1733.
8Merle P, Janicot H, Filaire M, et al. Early CYFRA 21-1 variation predicts tumor response to chemotherapy and survival in locally advanced non-small cell lung cancer patients [J]. Int J Biol Markers, 2004,19(4):310-315.
9Rolle A, Gunzel R, Pachmann U, et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC is a predictor for relapse: a preliminary report [J]. World J Surg Oncol, 2005,3 ( 1 ) : 18.
10Rosell R, Felip E, Maestre J, et al. The role of chemotherapy in early non-small cell lung cancer management [J]. J Lung Cancer, 2001,34(Suppl 3):S63-74.
